| |
Participants will:
- assess the biological rationale and the current clinical utility of pharmacological targeting of cancer angiogenesis, cell signal transduction, hypoxia and genetic alterations to increase the therapeutic ratio.
- assess the real and potential value of strategies that combine biological targeting with radiation therapy.
- identify the indications for and benefits and limitations to functional and molecular imaging techniques for biological target volumes.
- review principles of image guided radiation therapy and adaptation.
target audience
- radiation oncologists
- medical physicists
- radiation therapists
- cancer researchers
- residents and graduate students
conference focus
- molecular therapy
- biological targeting
- functional imaging
- state-of-the-art treatment planning &
delivery techniques in radiation oncology
topics
- radiation and antiangiogenesis
- radiation and gene therapy
- radiation and EGFR targeting
- radiation and hypoxia
- MRI simulation in radiation oncology
- PET for radiation therapy planning
- molecular imaging
- image guidance and adaptation
accreditation
- MDCB has awarded up to 11 credits
- University of Toronto Continuing Education has approved this event for 12 credit hours in Category 1 of the Physician's Recognition Award of the American Medical Association, and as an Accredited Group Learning Activity under Section 1 of the Framework of CPD options for the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
|
guest faculty
Clifford Chao
David Piwnica-Worms
Philip Tofilon
Pat Zanzonico
local faculty
Robert Bristow
Kristy Brock
Gregory Czarnota
Laura Dawson
Robert Dinniwell
Anthony Fyles
Mary Gospodarowicz
Richard Hill
David Jaffray
Fei-Fei Liu
Kathy Mah
Lee Manchul
Cynthia Menard
Michael Milosevic
Peter O'Brien
Jean-Philippe Pignol
Michael Sharpe
Lillian Siu
Yee Ung
Katherine Vallis
Shun Wong
Ivan Yeung
Sponsored by
the University of Toronto
Department of Radiation Oncology
|
